DocGo Inc. provided earnings guidance for the full year 2024. Full-year 2024 revenues are expected to be $720-750 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.89 USD | -2.03% |
|
-7.07% | -48.30% |
May. 09 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
May. 09 | Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.30% | 294M | |
-3.41% | 3B | |
+25.40% | 1.88B | |
0.00% | 1.79B | |
+63.15% | 682M | |
-14.98% | 441M | |
-27.24% | 160M | |
-17.05% | 131M | |
+1.92% | 67.85M |
- Stock Market
- Equities
- DCGO Stock
- News DocGo Inc.
- DocGo Inc. Provides Earnings Guidance for the Full Year 2024